The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 10, 2017

Filed:

Apr. 20, 2012
Applicants:

Anny Slama Schwok, Saint Auban, FR;

Bernard Delmas, Bourg-la-Reine, FR;

Stephane Quideau, Talence, FR;

Helene Bertrand, Paris, FR;

Bogdan Tarus, Montigny les Metz, FR;

Inventors:

Anny Slama Schwok, Saint Auban, FR;

Bernard Delmas, Bourg-la-Reine, FR;

Stephane Quideau, Talence, FR;

Helene Bertrand, Paris, FR;

Bogdan Tarus, Montigny les Metz, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 63/331 (2006.01); A61K 31/192 (2006.01); A61K 31/40 (2006.01); A61K 31/4196 (2006.01); A61K 31/5365 (2006.01); G01N 33/50 (2006.01); C07C 57/40 (2006.01);
U.S. Cl.
CPC ...
C07C 63/331 (2013.01); A61K 31/192 (2013.01); A61K 31/40 (2013.01); A61K 31/4196 (2013.01); A61K 31/5365 (2013.01); C07C 57/40 (2013.01); G01N 33/5008 (2013.01); G01N 2333/11 (2013.01);
Abstract

A pharmaceutical composition for treating viral infections by an influenza type A virus, includes a compound capable of acting as an inhibitor of the binding of the viral RNA to the nucleoprotein of influenza type A viruses, and capable of binding to the viral-RNA-binding domain on the nucleoprotein. A pharmaceutical composition for treating viral infections by an orthomyxovirus, includes a compound capable of acting as an inhibitor of the binding of the viral RNA to the nucleoprotein of orthomyxoviruses, and capable of binding to the viral-RNA-binding domain on the nucleoprotein of the viruses. A compound acting as an inhibitor of the binding of the viral RNA to the nucleoprotein of influenza type A viruses, and binding to the viral-RNA-binding domain on the nucleoprotein of influenza type A viruses and a method for identifying such a compound having these properties are also described.


Find Patent Forward Citations

Loading…